Alzheimer’s Patients May Be Getting Good News
Until recently, the only sort of medication available for Alzheimer’s patients has been to treat the symptoms of the disease rather than its cause. However, that’s changing now thanks to a research team working out of the University of London. After performing some very early trials, their drug, solanezumab, has apparently reduced the speed of degradation in an Alzheimer’s patient by 30 percent.
Specifically, the drug seems to lower the number of plaques that show up and cut off connections between brain cells. Physicians are still unclear as to whether these plaques are a cause or a direct effect of Alzheimer’s and dementia, but the fact that they’re decreasing in number, or at least appearing less quickly, is indication enough that the drug is working.
That’s significantly better than what our current drugs can manage, which is to add only a few months to a patient’s life (and that’s if the disease is caught early), and while it’s not a cure it’s at least a definite step in the right direction.
Unfortunately, thanks to all the health and safety standards in place to protect the public from new and untested drugs, the expected release date of solanezumab isn’t until 2025. That means that today’s Alzheimer’s patients aren’t likely to benefit from the drug, but it does mean that those who contract it in the future will be able to remain whole for longer than they can right now.
Hopefully the United States will have done something about its rapidly increasing prescription drug costs by then, but if not then patients will definitely need something like the USA Rx pharmacy discount card to cover their medication expenses. The USA Rx card works by offering alternative discounts on prescription drugs, sometimes up to 75 percent, and oftentimes these discounts are lower than an insurance plan’s copay.
Even better, unlike insurance benefits the USA Rx discount has no limit and no minimum cost. All you have to do is give us your name and an email address and we’ll send you a card free of charge. To find out more, you can email us at [email protected] or else call our toll-free number at 888-277-3911.